Therefore, the ability of C7 and C9 to interact with HIF1α, JAK2, PTGS2, and MMP9 suggests a multi-target approach that could effectively regulate inflammation, RA-FLS, immune response, and tissue degradation associated with RA. This evidence concerns the gene JAK2 and rheumatoid arthritis.